These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 34170459

  • 1. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
    Guan YQ, Shen KF, Yang L, Cai HD, Zhang ML, Wang JC, Long XL, Xiong J, Gu J, Zhang PL, Xiao M, Zhang W, Zhou JF.
    Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
    [Abstract] [Full Text] [Related]

  • 2. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
    Zheng M, Bao Y, Wang J, Ma Y, Yang Y, Zhang P, Chen L, Zheng K, Zhou J.
    Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
    [Abstract] [Full Text] [Related]

  • 3. Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.
    Gao LM, Zhao S, Zhang WY, Wang M, Li HF, Lizaso A, Liu WP.
    Cancer Biol Ther; 2019 Aug; 20(10):1319-1327. PubMed ID: 31311407
    [Abstract] [Full Text] [Related]

  • 4. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants.
    Ishimura M, Eguchi K, Shiraishi A, Sonoda M, Azuma Y, Yamamoto H, Imadome KI, Ohga S.
    Front Pediatr; 2019 Aug; 7():183. PubMed ID: 31231620
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S, NK-cell Tumor Study Group.
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [Abstract] [Full Text] [Related]

  • 6. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T.
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK.
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [Abstract] [Full Text] [Related]

  • 11. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
    Chen Z, Liu W, Zhang W, Ye Y, Guan P, Gao L, Zhao S.
    Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
    [Abstract] [Full Text] [Related]

  • 12. Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China.
    Dilmurat D, Wang X, Gao L, Tian J, Ai J, Zhang L, Liu M, Feng G, Zeng Y, Wang R, Xie Z.
    Ital J Pediatr; 2024 Jul 02; 50(1):125. PubMed ID: 38956696
    [Abstract] [Full Text] [Related]

  • 13. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
    Int J Clin Exp Pathol; 2014 Jul 02; 7(5):2430-7. PubMed ID: 24966953
    [Abstract] [Full Text] [Related]

  • 14. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group.
    Pathol Int; 2008 Apr 02; 58(4):209-17. PubMed ID: 18324913
    [Abstract] [Full Text] [Related]

  • 15. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L.
    Semin Diagn Pathol; 2020 Jan 02; 37(1):32-46. PubMed ID: 31889602
    [Abstract] [Full Text] [Related]

  • 16. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.
    Am J Dermatopathol; 2012 Dec 02; 34(8):e119-24. PubMed ID: 23169419
    [Abstract] [Full Text] [Related]

  • 17. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases.
    Luo H, Liu D, Liu W, Jin J, Bi X, Zhang P, Gu J, Zheng M, Xiao M, Liu X, Zhou J, Wang QF.
    J Allergy Clin Immunol; 2023 Apr 02; 151(4):1096-1109. PubMed ID: 36423698
    [Abstract] [Full Text] [Related]

  • 18. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
    Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S.
    Blood; 2012 Jan 19; 119(3):673-86. PubMed ID: 22096243
    [Abstract] [Full Text] [Related]

  • 19. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
    Cho EY, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH.
    J Korean Med Sci; 2008 Apr 19; 23(2):185-92. PubMed ID: 18436998
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.
    Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C, Bridges R, Lenoir C, BoutBoul D, Moshous D, Neven B, Kanda T, Morgan RG, White RE, Latour S, Farrell PJ.
    J Virol; 2022 Jun 22; 96(12):e0039422. PubMed ID: 35612313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.